Outcome prediction in large vessel occlusion ischemic stroke with or without endovascular stroke treatment: THRIVE-EVT

  • Alexander C. Flint (Creator)
  • Sheila L. Chan (Creator)
  • Nancy J. Edwards (Creator)
  • Vivek A. Rao (Creator)
  • Jeffrey G. Klingman (Creator)
  • Mai N. Nguyen-Huynh (Creator)
  • B. Yan (Creator)
  • Peter Mitchell (Creator)
  • Stephen Davis (Creator)
  • Bruce Campbell (Creator)
  • Diederik Dippel (Creator)
  • Yvo B.W.E.M. Roos (Creator)
  • Wim H. van Zwam (Creator)
  • J. L. Saver (Creator)
  • Stella M Kidwell (Creator)
  • Michael D. Hill (Creator)
  • Mayank Goyal (Creator)
  • Andrew M. Demchuk (Creator)
  • Serge Bracard (Creator)
  • Martin Bendszus (Creator)
  • Geoffrey A. Donnan (Creator)
  • P. J. Mitchell (Creator)
  • Bruce CV Campbell (Creator)
  • Diederik W Dippel (Creator)
  • Yvo BWEM Roos (Creator)
  • Wim H. van Zwam (Creator)
  • Chelsea S. Kidwell (Creator)
  • Mayank Goyal (Creator)
  • Andrew M. Demchuk (Creator)
  • Geoffrey A. Donnan (Creator)

Dataset

Description

Introduction:The THRIVE score and the THRIVE-c calculation are validated ischemic stroke outcome prediction tools based on patient variables that are readily available at initial presentation. Randomized controlled trials (RCTs) have demonstrated the benefit of endovascular treatment (EVT) for many patients with large vessel occlusion (LVO), and pooled data from these trials allow for adaptation of the THRIVE-c calculation for use in shared clinical decision making regarding EVT.Methods:To extend THRIVE-c for use in the context of EVT, we extracted data from the Virtual International Stroke Trials Archive (VISTA) from 7 RCTs of EVT. Models were built in a randomly selected development cohort using logistic regression that included the predictors from THRIVE-c: age, NIH Stroke Scale (NIHSS) score, presence of hypertension, diabetes mellitus, and/or atrial fibrillation, as well as randomization to EVT and, where available, the Alberta Stroke Program Early CT Score (ASPECTS).Results:Good outcome was achieved in 366/787 (46.5%) of subjects randomized to EVT and in 236/795 (29.7%) of subjects randomized to control (P Conclusion:THRIVE-EVT may be used alongside the original THRIVE-c calculation to improve outcome probability estimation for patients with acute ischemic stroke, including patients with or without LVO, and to model the potential improvement in outcomes with EVT for an individual patient based on variables that are available at initial presentation. Online calculators for THRIVE-c estimation are available at www.thrivescore.org and www.mdcalc.com/thrive-score-for-stroke-outcome.
Date made available2022
PublisherSAGE Journals

Cite this